<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469662</url>
  </required_header>
  <id_info>
    <org_study_id>CMU2014-06E</org_study_id>
    <nct_id>NCT02469662</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes Study of the Nexel Total Elbow</brief_title>
  <official_title>Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total&#xD;
      Elbow when used in primary or revision total elbow replacement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of the study are to confirm safety and performance of the Zimmer® Nexel™ Total&#xD;
      Elbow when used in primary or revision total elbow replacement by analysis of standard&#xD;
      scoring systems, radiographs, and adverse event records.&#xD;
&#xD;
      The safety of the device will be monitored using the frequency and incidence of reporting&#xD;
      adverse events.&#xD;
&#xD;
      The performance of the device will be evaluated by assessing the pain and functional&#xD;
      performance, survival of the device, patient health status, and radiographic success of the&#xD;
      implant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2028</completion_date>
  <primary_completion_date type="Anticipated">December 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survivorship</measure>
    <time_frame>10 years</time_frame>
    <description>Based on removal or intended removal of the device and determined using the Kaplan-Meier method</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Elbow Joint Destruction</condition>
  <condition>Post-traumatic Lesions</condition>
  <condition>Ankylosed Joints</condition>
  <condition>Advanced Rheumatoid Arthritis</condition>
  <condition>Joint Instability or Loss of Motion</condition>
  <condition>Acute Comminuted Articular Fracture of Elbow Joint Surfaces</condition>
  <condition>Bone Loss Contributing to Elbow Instability</condition>
  <condition>Bilateral Ankylosis From Causes Other Than Active Sepsis</condition>
  <condition>Post-traumatic Arthritis</condition>
  <condition>Degenerative Arthritis</condition>
  <arm_group>
    <arm_group_label>Retrospective</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who have had primary or revision total elbow arthroplasty using the Nexel Total Elbow, and who have surgical details available</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prospective</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who are having primary or revision total elbow arthroplasty who will receive the Nexel Total Elbow</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nexel Total Elbow</intervention_name>
    <description>Nexel Total Elbow used in primary or revision total elbow arthroplasty</description>
    <arm_group_label>Prospective</arm_group_label>
    <arm_group_label>Retrospective</arm_group_label>
    <other_name>Nexel Elbow</other_name>
    <other_name>Nexel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is 18 years of age or older.&#xD;
&#xD;
          -  Patient must have signed Institutional Review Board (IRB)/Ethics Committee&#xD;
             (EC)-approved informed consent.&#xD;
&#xD;
          -  Patient is a candidate for primary or revision total elbow arthroplasty, based on&#xD;
             symptoms including at least one of the following:&#xD;
&#xD;
               -  Elbow joint destruction which significantly compromises daily living activities&#xD;
&#xD;
               -  Post-traumatic lesions or bone loss contributing to elbow instability&#xD;
&#xD;
               -  Ankylosed joints, especially cases of bilateral ankylosis from causes other than&#xD;
                  active sepsis&#xD;
&#xD;
               -  Advanced rheumatoid arthritis, post-traumatic, or degenerative arthritis with&#xD;
                  incapacitating pain&#xD;
&#xD;
               -  Instability or loss of motion when the degree of joint or soft tissue damage&#xD;
                  precludes reliable osteosynthesis&#xD;
&#xD;
               -  Acute comminuted articular fracture of elbow joint surfaces that precludes less&#xD;
                  radical procedures, including 13-C3 fractures of the distal humerus&#xD;
&#xD;
          -  Patient is willing and able to complete scheduled follow-up evaluations as defined by&#xD;
             the protocol.&#xD;
&#xD;
        Additional Retrospective Arm Inclusion Criteria&#xD;
&#xD;
          -  Patient must have undergone a total elbow replacement with the Nexel system between&#xD;
             July 2013 and the date of the site initiation visit.&#xD;
&#xD;
          -  Patient information available for each retrospective patient must, at minimum, include&#xD;
             preoperative demographic information, preoperative physical exam information, the&#xD;
             index surgery operative report, and details of the devices implanted.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient has a currently active or history of repeated local infection at the surgical&#xD;
             site.&#xD;
&#xD;
          -  Patient has a current major infection distant from the operative site.&#xD;
&#xD;
          -  Patient has a history of prior sepsis.&#xD;
&#xD;
          -  Patient suffers from paralysis or dysfunctional neuropathy at the elbow joint.&#xD;
&#xD;
          -  Patient has significant ipsilateral hand dysfunction.&#xD;
&#xD;
          -  Patient has excessive scarring near the surgical site, which could prevent adequate&#xD;
             soft tissue coverage.&#xD;
&#xD;
          -  Patient participates in daily activities that may cause significant stress to an&#xD;
             implanted device such as heavy labor, torsional stress, and/or competitive sports.&#xD;
&#xD;
          -  Patient is a prisoner.&#xD;
&#xD;
          -  Patient is mentally incompetent or unable to understand what participation in the&#xD;
             study entails.&#xD;
&#xD;
          -  Patient is a known alcohol or drug abuser.&#xD;
&#xD;
          -  Patient is anticipated to be non-compliant.&#xD;
&#xD;
          -  Patient is known to be pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erin Osborn</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Madison Murphy</last_name>
    <phone>574-526-2059</phone>
    <email>madison.murphy@zimmerbiomet.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kacy Arnold, RN MBA</last_name>
    <phone>574-371-9824</phone>
    <email>kacy.arnold@zimmerbiomet.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Panorama Orthopedics and Spine Center</name>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <zip>80401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marlie Mounts</last_name>
      <phone>720-497-6697</phone>
      <email>mmounts@panoramaortho.com</email>
    </contact>
    <investigator>
      <last_name>David Schneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OrthoCarolina Research Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caleb Michalek, CCRC</last_name>
      <email>Caleb.Michalek@OrthoCarolina.com</email>
    </contact>
    <investigator>
      <last_name>Nady Hamid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Connor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thema Nicholson</last_name>
      <email>thema.nicholson@rothmaninstitute.com</email>
    </contact>
    <investigator>
      <last_name>Surena Namdari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Ramsey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Campbell Clinic</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Knack</last_name>
      <email>mknack@campbell-foundation.org</email>
    </contact>
    <investigator>
      <last_name>Thomas W Throckmorton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sydney Shoulder &amp; Elbow, NSW</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2067</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jeffery Hughes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coxa Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pirjo Honkanen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Purpan (Centre Hospitalier Universitaire Toulouse)</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pierre Mansat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arcus Sportklinik</name>
      <address>
        <city>Pforzheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Boris Hollinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hesperia Hospital</name>
      <address>
        <city>Modena</city>
        <zip>41100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Andrea Celli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amphia Ziekenhuis Breda</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Denise Eyendaal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wrightington</name>
      <address>
        <city>Wigan</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Adam Watts, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 8, 2015</study_first_submitted>
  <study_first_submitted_qc>June 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2015</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total Elbow Arthroplasty</keyword>
  <keyword>TEA</keyword>
  <keyword>Elbow Arthroplasty</keyword>
  <keyword>Elbow Replacement</keyword>
  <keyword>Advanced Rheumatoid Arthritis</keyword>
  <keyword>Post-Traumatic Arthritis</keyword>
  <keyword>Degenerative Arthritis</keyword>
  <keyword>Elbow Joint Destruction</keyword>
  <keyword>Post-Traumatic Lesions or Bone Loss</keyword>
  <keyword>Ankylosed Joints</keyword>
  <keyword>Acute Comminuted Articular Fracture</keyword>
  <keyword>Significantly compromises daily living activities</keyword>
  <keyword>Joint or soft tissue damage</keyword>
  <keyword>Precludes less radical procedures</keyword>
  <keyword>13-C3 fractures of the distal humerus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Joint Instability</mesh_term>
    <mesh_term>Ankylosis</mesh_term>
    <mesh_term>Fractures, Comminuted</mesh_term>
    <mesh_term>Intra-Articular Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

